Home NeoTX

NeoTX

In operation
Series C
Developer of Tumor Immunotherapy
Basic
Enterprise Profile

Basic Information

NeoTX is a professional biopharmaceutical company dedicated to the research and development of cancer immunotherapy. With a strong R&D team, their strategy is to build a patented, proprietary, and unique product pipeline to leverage technologies independently developed by NeoTX as well as those developed through partnerships and licensing agreements.
NeoTX Therapeutics Ltd.
Israel
15~50 people
January 01, 2015
--

Enterprise Profile

Industrial Sector
New Drug Development Biological Drug Production
Technology
Immunological Techniques
Concept
Therapeutic Products Lung Cancer
Application Scenarios
Innovative Drugs